Global Intragastric Balloon Market 2017-2023
Gastric balloon is a medical device that is used in an endoscopic intragastrical procedure, where the inflated silicone balloon is inserted in the stomach and is retained there for 6–12 months. This is widely known as weight loss balloon that is designed to help individuals to eat less and feel full sooner while eating. This makes less room for food and helps the body to adapt to healthy portions. This procedure is non-surgical, non-invasive, and requires no-incision. However, this procedure is not permanent and helps individual to lose up to three times the weight when compared to diet alone. Apart from weight loss it has many health benefits as it helps in improving diabetes, maintains cardiac health, and improves other bone-related issues.
Endoscopic bariatric therapies (EBT) have shown greater results and less adverse events. The delivery of EBT requires special room facility and preparation that will accommodate the size, weight, and surgical gowns for the patient.
The FDA approved products, such as Orbera intragastric balloon, the AspireAssist, and ReShape Integrated Dual Balloon have high signifiance in the market.
Intragastric balloon offers non-surgical and less invasive endoscopic procedure with reversible weight measurement that has grown in a scale with stronger impact on the market. Therefore, as more EBT are available for obese patients it will become more feasible and effective to offer long-term treatment in the future.
The major products in the market include:
- Spatz Adjustable Balloon system
- ReShape Duo Integrated DualBalloon System
- The Elipse
- Air-supplied Obalon Gastric Balloon
- Heliosphere BAG
The market is dominated by Apollo Endosurgery, Spatz FGIA, ReShape Medical, and Obalon Therapeutics, which has more than 90% market share in the Global Intragastric Balloon market. Factors, such as the increased prevalence of obesity, growing popularity about minimally non-invasive techniques, and the introduction of swallowable pills, are expected to boost the market growth.
The Global Intragastric Balloon Market is estimated to witness a CAGR of 9.6% during the forecast period 2017–2023. The market is analyzed based on three segments, namely product type, end-users, and regions.
The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (RoW). The Americas is set to be the leading region for the intragastric balloon market growth followed by Europe. Asia Pacific and RoW are set to be the emerging regions. The emerging markets have a high potential to grow owing to an increase in the number of obese population and its related chronic disorders. Further, the government is focusing toward improvising healthcare infrastructure and creating awareness among people for early prevention of diseases. Medical tourism is the new trend in emerging markets as most of the people from developed countries are traveling to APAC, especially India, for bariatric procedures. However, the high cost of intragastric balloons and expensive procedural costs, lack of skilled surgeons, lack of proper reimbursement policies, lack of awareness about gastric balloons in developed and developing countries have significant impact on the overall market growth.
Single intragastric balloon is growing at a steady rate and dominates the global intragastric balloon market with 55% of the total market share. Factors, such as the increasing obese population, rise in prevalence of chronic diseases, and rise in popularity of minimally non-invasive techniques, are driving the market growth. The is one of the first and well-known gastric balloon used since the introduction of intragastric balloons in the market. The popularity of single intragastric balloon for its non-invasive technique and alternative to undergo the knife has increased the adoption of gastric balloons in the market accounting for 50% of the total market share. Orbera by Apollo Endosurgery is one of the most popular single gastric balloon that received FDA clearance in August 2015. This product is also known as BIB (BioEnterics Intragastric Balloon). It is made of silicone and filled with saline after endoscopic transoral placement inside the patient’s stomach.
Apollo Endosurgery, Spatz FGIA, ReShape Medical, and Obalon Therapeutics, and other predominant & niche players.
The global intragastric balloon market has immense growth opportunities for vendors in both developed and developing regions. The market in the developed countries is seeing an increase in the adoption of gastric balloons, especially in the US, Canada, France, Germany, and the UK and few of the Middle East Countries. These countries have the highest obese population accounting to 70% to 75% of the total obese population worldwide. Major vendors are directly competing with primary bariatric invasive surgical companies for replacing surgeries such as sleeve gastrectomy, gastric bypass, and various laparoscopy surgeries. Most of the companies, including tier II companies also focus on building a strong relationship with the customers and physicians to have direct sales and product revenue generation. The growing awareness about the products and rise in number of physician-owned implant distributions that have resulted in the rise in volume of intragastric balloon procedures have led individuals undergo treatment for obesity.
The report provides complete details about the usage and adoption rate of intragastric balloons for the treatment of obesity. Therefore, the key stakeholders can know about the major trends, drivers, investments, vertical player’s initiatives, and government initiatives toward the intragastric balloon adoption in the upcoming years. They can also get details of the pureplay companies entering the market. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders in order to expand their business and capture the revenue in specific verticals, and to analyze before investing or expanding the business in this market.
1 Industry Outlook
1.1 Industry Overview
1.2 Emerging Global Markets
1.3 Weight related disorders
1.4 Industry Trends
2 Report Outline
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 Market Snapshot
3.1 Total Addressable Market (TAM)
3.2 Segmented Addressable Market (SAM)
3.2.2 Importance of intragastric balloon
3.2.3 Single Intragastric Balloon
3.2.4 Dual Intragastric Balloon
3.2.5 Triple Intragastric Balloon
3.3 Related Markets
3.3.1 Breast Implant Market
3.3.2 Dental Implant Market
3.3.3 Facial Implant Market
4 Market Outlook
4.2 PEST Analysis
4.3 Porter 5(Five) Forces
5 Market Characteristics
5.2 DRO – Global Intragastric Balloon Market Dynamics
22.214.171.124 Rise in the prevalence of obesity
126.96.36.199 Increase prevalence of chronic diseases
188.8.131.52 Increasing popularity of MI techniques
184.108.40.206 Increase in number of outpatient procedure
220.127.116.11 Emerging endo-bariatric technology for treating obesity
18.104.22.168 Increase healthcare spending
22.214.171.124 Rise in medical tourism
126.96.36.199 High cost of intragastric balloon procedures
188.8.131.52 Alternative techniques for treatment of obesity
184.108.40.206 Complications and risk associated with spine surgeries
220.127.116.11 Stringent regulatory framework and labeling requirement
18.104.22.168 Poor reimbursement policies
22.214.171.124 Intense competition among vendors
5.2.4 DRO – Impact Analysis
5.2.5 Key Stakeholders
6 Types: Market Size and Analysis
6.2 Single Intragastric Balloon
6.3 Dual Intragastric Balloon
6.4 Triple Intragastric Balloon
7 End User: Market Size and Analysis
7.2 Bariatric Surgical Centers
7.3 Ambulatory Surgical Care
8 Regions: Market Size and Analysis
8.2 North America
8.2.1 Market Overview
8.3.1 Market Overview
8.4.1 Market Overview
8.5 Rest of the World
8.5.1 Market Overview
9 Competitive Landscape
10 Vendor Profiles
10.1 Apollo Endosurgery, Inc.
10.1.2 Business Unit
10.1.3 Geographic Presence
10.1.4 Business Focus
10.1.5 SWOT Analysis
10.1.6 Business Strategy
10.2 OBALON THERAPEUTICS, INC.
10.2.2 Business Focus
10.2.3 SWOT Analysis
10.2.4 Business Strategy
10.3 Spatz FGIA, Inc.
10.4 ReShape Medical Inc.
TABLE 1 CATEGORIZATION OF INDIVIDUALS WITH BMI 10
TABLE 1 COMPARISON OF DIFFERENT BARIATRIC SURGERY COST IN DEVELOPED AND DEVELOPING NATIONS 25
TABLE 2 COMPARISON OF INTRAGASTRIC BALLOON PROCEDURE WITH AND WITHOUT INSURANCE IN 2016 ($) 26
TABLE 3 ALTERNATE TECHNIQUES FOR TREATMENT OF OBESITY 26
TABLE 4 GLOBAL INTRAGSTRIC BALLOON MARKET BY TYPES, 2016–2023 ($MILLION) 33
TABLE 5 GLOBAL INTRAGASTRIC BALLOON MARKET BY END-USERS 41
TABLE 6 GLOBAL INTRAGASTRIC BALLOON MARKET REVENUE BY REGIONS FORECAST, 2016–2023 ($MILLION) 44
TABLE 7 DRO (NORTH AMERICA) 45
TABLE 8 DRO (EUROPE) 47
TABLE 9 DRO (APAC) 49
TABLE 10 DRO (REST OF THE WORLD) 51
TABLE 11 APOLLO ENDOSURGERY, INC.: PRODUCT OFFERINGS 54
TABLE 12 APOLLO ENDOSURGERY, INC.: RECENT DEVELOPMENTS 54
TABLE 13 OBALON THERAPEUTICS, INC: RECENT DEVELOPMENTS 59
Infoholic Research works on a holistic 360° approach in order to deliver high quality, validated and reliable information in our market reports. The Market estimation and forecasting involves following steps:
- Data Collation (Primary & Secondary)
- In-house Estimation (Based on proprietary data bases and Models)
- Market Triangulation
Market related information is congregated from both primary and secondary sources.
Involved participants from all global stakeholders such as Solution providers, service providers, Industry associations, thought leaders etc. across levels such as CXOs, VPs and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.
Include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications along with paid sources such as Factiva, OneSource, Bloomberg among others.